Lgmn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Lgmn Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Legumain | |
|---|---|
| Gene Symbol | LGMN |
| Full Name | Legumain |
| Chromosome | 14q32.12 |
| NCBI Gene ID | 5648 |
| OMIM | 607216 |
| Ensembl ID | ENSG00000100600 |
| UniProt ID | Q99538 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Macrophage Migration Inhibitory Factor |
LGMN encodes legumain, an asparagine-specific cysteine protease that cleaves proteins at asparagine residues. Legumain is involved in protein catabolism, antigen processing, and the activation of other proteases. It plays a role in the degradation of extracellular matrix proteins and is implicated in tumor invasion and metastasis.
Expressed in most tissues, with high expression in kidney, placenta, and brain. In the brain, expressed in neurons and microglia.
| Disease | Role | Mechanism |
|---|---|---|
| Alzheimer's Disease | Risk factor | Enhanced legumain activity promotes amyloid-beta formation |
| Parkinson's Disease | Risk factor | Regulates alpha-synuclein degradation |
Lgmn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Lgmn Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.